Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
November 5, 2010 Intrauterine Fetal demise Perinatal 85% HSV from maternal genital tract Often asymptomatic Higher risk with primary infection Postnatal Rare 10% Caretaker with active HSV Maternal outbreak at delivery Primary infection: transmission 25%-60% Reactivated infection: transmission 2% Nearly impossible to discern clinically >75% of infants with HSV are born to women with negative history and physical Three Skin, eye, mouth (SEM) Central nervous system (CNS) Disseminated May categories (may overlap) be caused by HSV-1 or HSV-2 HSV-2 worse prognosis Most common first 2wks Seen up to 6wks Perform thorough evaluation for CNS and disseminated dz Favorable outcome if treated early Most Seen up to 6wks May common first 2wks occur with or without SEM Up to 70% have skin findings Clinical manifestations Seizures Lethargy Full fontanel Systemic signs: Irritability, tremors, poor feeding, temp instability, apnea Most survive, but with substantial sequelae Consider imaging Early Intervention Liver, lungs, adrenals, CNS, skin, eye, mouth Neutropenia, DIC CNS in 70% Maternal fever is risk factor Usually presents 1st week of life Advanced cases may present with hypothermia, respiratory failure and shock Skin vesicles may appear late Absent in 20% Complications Respiratory failure: intubation Liver failure: transplantation If untreated, mortality 80% Often diagnoses at autopsy Sepsis syndrome, negative bacterial cultures, liver dysfunction Sepsis syndrome, abnormal CSF especially in setting of neonatal seizure Cell culture Mouth Nasopharynx Conjunctivae Rectum CSF (skin vescicles and blood) Direct Fluorescent Antibody staining Vesicular scrapings PCR useful for CSF Tzanck test has low sensitivity and is outdated Parenteral If acyclovir 60mg/kg/day in 3 divided doses 14 days for SEM 21 days for CNS or disseminated ocular involvement, add topical drops Cesarean delivery if active lesions present Decreases risk of neonatal HSV Maternal history is not an indication for C/S Avoid fetal scalp monitors during labor Infants infected or exposed during delivery Contact precautions Continuous rooming in with mom in private room Postpartum women with HSV infection Breastfeeding is allowed No lesions on breasts Any other lesions are covered Maternal Obtain cultures at 12-24hrs of life Mouth, nasopharynx, conjunctivae, rectum Maternal active genital HSV at birth first-episode genital lesions ?Start empiric acyclovir Careful exam and observation Educate caretakers of warning signs